Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
Public ClinicalTrials.gov record NCT00874497. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Phase 2a multicenter, randomized, double-blind, placebo-controlled study to assess the pharmacodynamics, efficacy, and safety of tetomilast in patients with emphysema.
Study identification
- NCT ID
- NCT00874497
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 84 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2009 (Type not available)
- Primary completion
- Jul 2015 (Actual)
- Completion
- Aug 2015 (Actual)
- Last update posted
- Apr 17, 2017
2009 – 2015
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Lung Health Center | Birmingham | Alabama | 35294 | — |
| Los Angeles Biomedical Institute | Torrance | California | 90502 | — |
| Pulmonary Disease Specialist/PDS Research | Kissimmee | Florida | 34741 | — |
| Well Pharma Medical Research | Miami | Florida | 33143 | — |
| Florida Premier Research Institute | Winter Park | Florida | 32789 | — |
| Georgia Clinical Research | Austell | Georgia | 30106 | — |
| Illinios Lung Institute | Peoria | Illinois | 61606 | — |
| University of Louisville, Pulmonary Division | Louisville | Kentucky | 40202 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| Temple University Hospital | Philadelphia | Pennsylvania | 19140 | — |
| Spartanburg Medical Research | Spartanburg | South Carolina | 29303 | — |
| Texas Institute of Chest and Sleep Disorders, PA | Houston | Texas | 77034 | — |
| Diagnostics Research Group | San Antonio | Texas | 78229 | — |
| Pulmonary Associates of Richmond | Richmond | Virginia | 23225 | — |
| Multicare Pulmonary Specialist | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00874497, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 17, 2017 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00874497 live on ClinicalTrials.gov.